Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
Holding CTNM?
Track your performance easily

Contineum Therapeutics, Inc. Class A (CTNM) Ownership - Who Owns Contineum Therapeutics, Inc. Class A?

168 Followers

Contineum Therapeutics, Inc. Class A (CTNM) Ownership Overview

2.82%7.95%4.82%3.76%80.65%
4.82% Other Institutional Investors
3.76% ETFs
80.65% Public Companies and
Individual Investors
The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 16.53% of the company’s stock is owned by Institutional Investors, 2.82% is owned by Insiders, and 80.65% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
918,163Institution4.82%17,757,272
900,000Institution4.72%17,406,000
523,847Insider2.75%10,131,201
446,019Institution2.34%8,626,007
425,006Institution2.23%8,219,616
392,800Institution2.06%7,596,752
312,500Institution1.64%6,043,750
258,800Institution1.36%5,005,192
217,356Institution1.14%4,203,665
216,967Institution1.14%4,196,142

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
425,006Institution2.23%8,219,616
392,800Institution2.06%7,596,752
258,800Institution1.36%5,005,192
216,967Institution1.14%4,196,142
73,947Institution0.39%1,430,135
70,557Institution0.37%1,364,572
34,407Institution0.18%665,431
19,870Institution0.10%384,286
9,388Institution0.05%181,564
6,016Institution0.03%116,349

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
299,583Institution1.57%5,734,019
151,933Institution0.80%2,938,384
115,078Institution0.60%2,202,593
28,013Institution0.15%541,771
26,200Institution0.14%501,468
26,436Institution0.14%486,422
24,433Institution0.13%472,534
12,887Institution0.07%249,235
4,858Institution0.03%93,954
3,224Institution0.02%61,707

FAQ

Who Owns Contineum Therapeutics, Inc. Class A (CTNM)?
According to the latest TipRanks data, approximately 4.82% of the company's stock is held by institutional investors, 2.82% is held by insiders, and 80.65% is held by retail investors.
    What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 4.82% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors.
      What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 80.65% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors.
        Who owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM)?
        Brad Bolzon owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis